Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Geriatrics | Infections | Internal Medicine | Nursing | Pathology | Pharmacy | Institutional

Back to Journal Articles

Moderna COVID-19 Vaccine 90 Percent Effective Six Months After Second Dose

Last Updated: April 14, 2021.

WEDNESDAY, April 14, 2021 (HealthDay News) -- The Moderna two-dose COVID-19 vaccine continues to provide strong protection against the new coronavirus six months after people have received their second shot, the company reported Tuesday.

It said that findings from its late-stage trial follow-up showed that six months after the second dose, the vaccine remained 90 percent effective against all cases of COVID-19 and 95 percent effective against severe cases of the disease, The Washington Post reported.

Moderna also said that it is testing vaccine candidates that target specific variants of the new coronavirus, including the B.1.351 variant first detected in South Africa. Some studies have suggested that the variant can escape immunity provided by current vaccines. One of the candidates combines the vaccine targeting the B.1.351 variant with the original Moderna shot, which the company said "provided the broadest level of immunity" when tested on mice, The Post reported.

The company said its early results on vaccines that target specific variants would be submitted for peer-reviewed publication, The Post reported.

The Washington Post Article


Previous: Trump Ban on Clinic Abortion Referrals to Be Reversed‚Äč Next: CDC: U.S. STD Rate at Record High Again

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: